Private Advisor Group LLC Sells 500 Shares of VanEck Biotech ETF (NASDAQ:BBH)

Private Advisor Group LLC cut its holdings in VanEck Biotech ETF (NASDAQ:BBH) by 26.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,375 shares of the company’s stock after selling 500 shares during the period. Private Advisor Group LLC’s holdings in VanEck Biotech ETF were worth $216,000 at the end of the most recent quarter.

Several other institutional investors have also bought and sold shares of BBH. Truvestments Capital LLC purchased a new stake in shares of VanEck Biotech ETF during the third quarter worth $44,000. FSA Wealth Management LLC bought a new position in VanEck Biotech ETF in the third quarter valued at $54,000. Coastline Trust Co bought a new position in shares of VanEck Biotech ETF during the third quarter valued at about $59,000. Wilmington Savings Fund Society FSB bought a new position in shares of VanEck Biotech ETF during the third quarter valued at about $166,000. Finally, Tyler Stone Wealth Management grew its stake in shares of VanEck Biotech ETF by 79.5% during the third quarter. Tyler Stone Wealth Management now owns 1,472 shares of the company’s stock valued at $261,000 after buying an additional 652 shares during the last quarter. Hedge funds and other institutional investors own 32.05% of the company’s stock.

VanEck Biotech ETF Stock Performance

NASDAQ BBH opened at $164.60 on Friday. The stock has a market cap of $401.62 million, a P/E ratio of 30.97 and a beta of 0.85. The stock has a 50 day simple moving average of $161.88 and a two-hundred day simple moving average of $168.68. VanEck Biotech ETF has a fifty-two week low of $151.35 and a fifty-two week high of $183.64.

VanEck Biotech ETF Dividend Announcement

The business also recently disclosed a dividend, which was paid on Tuesday, December 24th. Shareholders of record on Monday, December 23rd were issued a $1.2517 dividend. The ex-dividend date was Monday, December 23rd.

About VanEck Biotech ETF

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.